In clinical practice, the definition of HED profiles at HLA-A and HLA-B loci can guide the formulation of disease management and prevention strategies, including the development of vaccines, for which immunogenetic diversity and hence immune responses could significantly improve efficacy in heterogeneous populations [34,35]. This evidence concerns the gene HLA-A and hypohidrotic ectodermal dysplasia.